All Audiences

Legal advocacy

LLS Experts: CAR T-therapy Benefits Outweigh Risks for Appropriate Patients

Leukemia Survivor Named National ‘Visionary of the Year’ Redefining What’s Possible After Diagnosis

The Leukemia & Lymphoma Society’s Light The Night Events Lead the Charge Against Blood Cancer

The Leukemia & Lymphoma Society Rings Nasdaq Bell to Mark 75 Years of Progress and Announce its Bold Goal for the Future

The Leukemia & Lymphoma Society Names Lore Gruenbaum, Ph.D., New Chief Scientific Officer

The Leukemia & Lymphoma Society (LLS) Invests Nearly $6.5 Million in Research Investigating the Causes of Inequitable Access to Blood Cancer Treatment and Care

The Leukemia & Lymphoma Society Honors Five Outstanding Blood Cancer Scientists with 2023 Awards

Skies Across North America to Light Up This Fall in Support of Blood Cancer Patients

The Follicular Lymphoma Foundation Joins Forces With The Leukemia & Lymphoma Society to Bring Hope to Those Living With Follicular Lymphoma

Subscribe to All Audiences

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.